Cardiovascular Diseases

J&J intends to split into two companies, separating consumer products and pharmaceutical businesses  On November 12, 2021, Johnson & Johnson announced its plans to split the Company’s Consumer Health business, forming a new publicly traded company. This will help the company create two global leaders that are well-positioned to provide enhanced health outcomes for patients and consumers through innovation, continue more targeted business strategies and expedite growth.  This will result in the separation of its domestic products unit, maker of Band-Aid bandages, Aveeno and Neutrogena skincare products, and Listerine, from its riskier but faster-grow...